Drug class in one race
NLRP3 inflammasome drugs for Atherosclerotic Cardiovascular Disease
3 tracked NLRP3 inflammasome drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the NLRP3 inflammasome page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.
2 Phase 21 Phase 1
Head-to-head evidence: ABP-745 vs AZD4144 · AZD4144 vs Selnoflast